Illicit methylphenidate use among Iranian medical students: Prevalence and knowledge

Afshin Habibzadeh, Mahasti Alizadeh, Ayoub Malek, Leili Maghbooli, Mohammadali Mohajel Shoja, Kamyar Ghabili

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Methylphenidate, a medication prescribed for individuals suffering from attentiondeficit/ hyperactivity disorder, is increasingly being misused by students. Objective: The aims of this study were to evaluate the frequency of methylphenidate use among a group of Iranian medical students and to assess their knowledge of methylphenidate. Methods: Anonymous, self-administered questionnaires were completed by all medical students entering the university between 2000 and 2007. Results: Methylphenidate users' mean knowledge score was higher than that of nonusers (15.83 ± 3.14 vs 13.66 ± 3.10, P = 0.008). Age, gender, and school year were positively correlated with knowledge score (P < 0.05). Data analysis demonstrated that 27 participants (8.7%) had taken methylphenidate at least once in their lifetime. The respondents believed that the most common motive for methylphenidate use among youths was that it aided concentration and therefore ability to study. Conclusion: This study indicates a relatively low level of knowledge about methylphenidate among Iranian medical students. More educational programs regarding the use of methylphenidate are required and should be focused on the student suppliers, clinicians, pharmacists, and medical students.

Original languageEnglish (US)
Pages (from-to)71-76
Number of pages6
JournalDrug Design, Development and Therapy
Issue number5
DOIs
StatePublished - Mar 28 2011
Externally publishedYes

Fingerprint

Methylphenidate
Medical Students
Students
Pharmacists

Keywords

  • Iran
  • Medical student
  • Methylphenidate
  • Prevalence

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery

Cite this

Habibzadeh, A., Alizadeh, M., Malek, A., Maghbooli, L., Mohajel Shoja, M., & Ghabili, K. (2011). Illicit methylphenidate use among Iranian medical students: Prevalence and knowledge. Drug Design, Development and Therapy, (5), 71-76. https://doi.org/10.2147/DDDT.S13818

Illicit methylphenidate use among Iranian medical students : Prevalence and knowledge. / Habibzadeh, Afshin; Alizadeh, Mahasti; Malek, Ayoub; Maghbooli, Leili; Mohajel Shoja, Mohammadali; Ghabili, Kamyar.

In: Drug Design, Development and Therapy, No. 5, 28.03.2011, p. 71-76.

Research output: Contribution to journalArticle

Habibzadeh, A, Alizadeh, M, Malek, A, Maghbooli, L, Mohajel Shoja, M & Ghabili, K 2011, 'Illicit methylphenidate use among Iranian medical students: Prevalence and knowledge', Drug Design, Development and Therapy, no. 5, pp. 71-76. https://doi.org/10.2147/DDDT.S13818
Habibzadeh, Afshin ; Alizadeh, Mahasti ; Malek, Ayoub ; Maghbooli, Leili ; Mohajel Shoja, Mohammadali ; Ghabili, Kamyar. / Illicit methylphenidate use among Iranian medical students : Prevalence and knowledge. In: Drug Design, Development and Therapy. 2011 ; No. 5. pp. 71-76.
@article{1574eba0391d4f429a29d4a9ad098f1d,
title = "Illicit methylphenidate use among Iranian medical students: Prevalence and knowledge",
abstract = "Background: Methylphenidate, a medication prescribed for individuals suffering from attentiondeficit/ hyperactivity disorder, is increasingly being misused by students. Objective: The aims of this study were to evaluate the frequency of methylphenidate use among a group of Iranian medical students and to assess their knowledge of methylphenidate. Methods: Anonymous, self-administered questionnaires were completed by all medical students entering the university between 2000 and 2007. Results: Methylphenidate users' mean knowledge score was higher than that of nonusers (15.83 ± 3.14 vs 13.66 ± 3.10, P = 0.008). Age, gender, and school year were positively correlated with knowledge score (P < 0.05). Data analysis demonstrated that 27 participants (8.7{\%}) had taken methylphenidate at least once in their lifetime. The respondents believed that the most common motive for methylphenidate use among youths was that it aided concentration and therefore ability to study. Conclusion: This study indicates a relatively low level of knowledge about methylphenidate among Iranian medical students. More educational programs regarding the use of methylphenidate are required and should be focused on the student suppliers, clinicians, pharmacists, and medical students.",
keywords = "Iran, Medical student, Methylphenidate, Prevalence",
author = "Afshin Habibzadeh and Mahasti Alizadeh and Ayoub Malek and Leili Maghbooli and {Mohajel Shoja}, Mohammadali and Kamyar Ghabili",
year = "2011",
month = "3",
day = "28",
doi = "10.2147/DDDT.S13818",
language = "English (US)",
pages = "71--76",
journal = "Drug Design, Development and Therapy",
issn = "1177-8881",
publisher = "Dove Medical Press Ltd.",
number = "5",

}

TY - JOUR

T1 - Illicit methylphenidate use among Iranian medical students

T2 - Prevalence and knowledge

AU - Habibzadeh, Afshin

AU - Alizadeh, Mahasti

AU - Malek, Ayoub

AU - Maghbooli, Leili

AU - Mohajel Shoja, Mohammadali

AU - Ghabili, Kamyar

PY - 2011/3/28

Y1 - 2011/3/28

N2 - Background: Methylphenidate, a medication prescribed for individuals suffering from attentiondeficit/ hyperactivity disorder, is increasingly being misused by students. Objective: The aims of this study were to evaluate the frequency of methylphenidate use among a group of Iranian medical students and to assess their knowledge of methylphenidate. Methods: Anonymous, self-administered questionnaires were completed by all medical students entering the university between 2000 and 2007. Results: Methylphenidate users' mean knowledge score was higher than that of nonusers (15.83 ± 3.14 vs 13.66 ± 3.10, P = 0.008). Age, gender, and school year were positively correlated with knowledge score (P < 0.05). Data analysis demonstrated that 27 participants (8.7%) had taken methylphenidate at least once in their lifetime. The respondents believed that the most common motive for methylphenidate use among youths was that it aided concentration and therefore ability to study. Conclusion: This study indicates a relatively low level of knowledge about methylphenidate among Iranian medical students. More educational programs regarding the use of methylphenidate are required and should be focused on the student suppliers, clinicians, pharmacists, and medical students.

AB - Background: Methylphenidate, a medication prescribed for individuals suffering from attentiondeficit/ hyperactivity disorder, is increasingly being misused by students. Objective: The aims of this study were to evaluate the frequency of methylphenidate use among a group of Iranian medical students and to assess their knowledge of methylphenidate. Methods: Anonymous, self-administered questionnaires were completed by all medical students entering the university between 2000 and 2007. Results: Methylphenidate users' mean knowledge score was higher than that of nonusers (15.83 ± 3.14 vs 13.66 ± 3.10, P = 0.008). Age, gender, and school year were positively correlated with knowledge score (P < 0.05). Data analysis demonstrated that 27 participants (8.7%) had taken methylphenidate at least once in their lifetime. The respondents believed that the most common motive for methylphenidate use among youths was that it aided concentration and therefore ability to study. Conclusion: This study indicates a relatively low level of knowledge about methylphenidate among Iranian medical students. More educational programs regarding the use of methylphenidate are required and should be focused on the student suppliers, clinicians, pharmacists, and medical students.

KW - Iran

KW - Medical student

KW - Methylphenidate

KW - Prevalence

UR - http://www.scopus.com/inward/record.url?scp=79952955079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952955079&partnerID=8YFLogxK

U2 - 10.2147/DDDT.S13818

DO - 10.2147/DDDT.S13818

M3 - Article

C2 - 21340040

AN - SCOPUS:79952955079

SP - 71

EP - 76

JO - Drug Design, Development and Therapy

JF - Drug Design, Development and Therapy

SN - 1177-8881

IS - 5

ER -